Latest News & Features
Americas
Japan-based Astellas Pharma has acquired US-based Universal Cells in a move that will allow it to develop universal donor cell technology. 16 February 2018
Americas
Biotechnology company United Therapeutics has reached a settlement with Actavis Laboratories to resolve a dispute over patents concerning a blood pressure drug. 16 February 2018
Americas
The US International Trade Commission will be launching a patent infringement investigation into microfluidic systems, following a complaint from 10x Genomics. 15 February 2018
Americas
Bristol-Myers Squibb has agreed to pay $1.85 billion for an immuno-oncology programme. 15 February 2018
Americas
French cell therapy company Cellectis has announced plans to make two CRISPR patents, which were recently granted by the US Patent and Trademark Office, available for licensing. 14 February 2018
Americas
Japan-based Sumitomo Dainippon Pharma has taken on Indian generics company Emcure Pharmaceuticals over an antipsychotic drug. 14 February 2018
Big Pharma
LSIPR attended a packed UK Supreme Court yesterday for day one of a four-day hearing, with Warner-Lambert debating the role that plausibility plays in patent law. Below we provide an overview of the case and its core issues. 13 February 2018
Americas
Global law firm Ropes & Gray has welcomed Filko Prugo to its New York office as partner and chair of the life sciences IP practice. 12 February 2018
Americas
The US Court of Appeals for the Federal Circuit denied Merck Sharp & Dohme’s request for a new trial to determine whether Amneal infringed a patent related to a nasal spray on Friday, February 9. 12 February 2018
Asia-Pacific
Allergan is set to acquire Australia-based Elastagen, a clinical-stage company focused on developing medical device products based on recombinant tropoelastin, for $95 million. 12 February 2018